OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
UPXI$1.5258

Upexi, Inc

Personal ProductsVerified

Upexi, Inc has a market capitalization of $106.04 million and a price-to-book ratio of 4.81, indicating that the market is valuing the company at a premium to its book value. The company's liquidity position is characterized by a current ratio of 0.7, suggesting that it has less current assets than current liabilities, which could pose a liquidity risk. The debt-to-equity ratio of 1.21 indicates that the company is financed by a combination of debt and equity, with a slight tilt towards debt. In terms of profitability, Upexi, Inc reported a net loss of $4.12 million and an operating loss of $5.04 million, which is significantly below the industry median for profitability metrics. The return on equity of -18.67% and return on assets of -7.29% further underscore the company's unprofitable operations. These figures suggest that the company is not generating returns that meet the expectations of its shareholders or asset base. The company's revenue is concentrated in a single business segment, as there are no disclosed segments, and there is no information on geographic exposure. This lack of diversification could expose the company to higher risk if the personal products market experiences a downturn. The growth trajectory of Upexi, Inc is not clearly defined, as there is no outlook data provided for the current or next fiscal year. The company's operating cash flow is negative at -$2.82 million, and its free cash flow is also negative at -$1.96 million, indicating that the company is not generating sufficient cash from operations to fund its activities. The risk assessment for Upexi, Inc highlights a medium liquidity risk and a low dilution risk. The company's capital structure includes a significant amount of long-term debt, which could lead to financial distress if the company is unable to meet its debt obligations. The risk of dilution is low, as there is no indication of a large number of shares outstanding or a potential for a significant increase in shares. Recent events related to Upexi, Inc include analyst estimates that suggest a wide range of price targets, from $2.00 to $8.00, with a mean and median price target of $5.00. The mean recommendation from analysts is 2.00, which is a "Buy" rating, indicating that analysts are generally optimistic about the company's future performance.

30-day price · UPXI+0.44 (+43.6%)
Low$0.92High$1.55Close$1.45As of17 May, 00:00 UTC
Profile
CompanyUpexi, Inc
TickerUPXI.O
SectorConsumer Non-Cyclicals
BusinessPersonal & Household Products & Services
Industry groupPersonal & Household Products & Services
IndustryPersonal Products
AI analysis

Business. Upexi, Inc is a personal products company that offers a range of consumer goods within the personal care segment, generating revenue primarily through the sale of these products to consumers.

Classification. Upexi, Inc is classified under the Consumer Non-Cyclicals economic sector, Personal & Household Products & Services business sector, and Personal Products industry, with a classification confidence of 0.92.

Upexi, Inc has a market capitalization of $106.04 million and a price-to-book ratio of 4.81, indicating that the market is valuing the company at a premium to its book value. The company's liquidity position is characterized by a current ratio of 0.7, suggesting that it has less current assets than current liabilities, which could pose a liquidity risk. The debt-to-equity ratio of 1.21 indicates that the company is financed by a combination of debt and equity, with a slight tilt towards debt. In terms of profitability, Upexi, Inc reported a net loss of $4.12 million and an operating loss of $5.04 million, which is significantly below the industry median for profitability metrics. The return on equity of -18.67% and return on assets of -7.29% further underscore the company's unprofitable operations. These figures suggest that the company is not generating returns that meet the expectations of its shareholders or asset base. The company's revenue is concentrated in a single business segment, as there are no disclosed segments, and there is no information on geographic exposure. This lack of diversification could expose the company to higher risk if the personal products market experiences a downturn. The growth trajectory of Upexi, Inc is not clearly defined, as there is no outlook data provided for the current or next fiscal year. The company's operating cash flow is negative at -$2.82 million, and its free cash flow is also negative at -$1.96 million, indicating that the company is not generating sufficient cash from operations to fund its activities. The risk assessment for Upexi, Inc highlights a medium liquidity risk and a low dilution risk. The company's capital structure includes a significant amount of long-term debt, which could lead to financial distress if the company is unable to meet its debt obligations. The risk of dilution is low, as there is no indication of a large number of shares outstanding or a potential for a significant increase in shares. Recent events related to Upexi, Inc include analyst estimates that suggest a wide range of price targets, from $2.00 to $8.00, with a mean and median price target of $5.00. The mean recommendation from analysts is 2.00, which is a "Buy" rating, indicating that analysts are generally optimistic about the company's future performance.
Key takeaways
  • Upexi, Inc is currently unprofitable, with a net loss and operating loss, and a negative return on equity and assets.
  • The company's liquidity position is weak, as indicated by a current ratio of 0.7 and a negative operating cash flow.
  • The company's capital structure is heavily leveraged, with a debt-to-equity ratio of 1.21.
  • Analysts have a generally positive outlook on the company, with a mean recommendation of "Buy" and a mean price target of $5.00.
  • # RATIONALES
  • margin_outlook_rationale: The company's margin outlook is negative due to its unprofitable operations and negative return on equity and assets.
  • rd_outlook_rationale: There is no information provided on the company's research and development activities or outlook.
  • capex_outlook_rationale: The company's capital expenditure is negative, indicating a reduction in investment in long-term assets.
Financial snapshot
PeriodHA-latest
CurrencyUSD
Revenue$5.2M
Gross profit$1.3M
Operating income-$5.0M
Net income-$4.1M
R&D
SG&A
D&A
SBC
Operating cash flow-$2.8M
CapEx-$663.1k
Free cash flow-$2.0M
Total assets$56.5M
Total liabilities$34.5M
Total equity$22.1M
Cash & equivalents
Long-term debt$26.7M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$24.1M$2.2M$3.0M$2.5M
FY-3$23.1M-$6.2M-$2.1M-$9.8M
FY-2$36.4M-$12.3M-$16.9M-$11.4M
FY-1$26.0M-$22.5M-$23.7M-$22.5M
FY0$15.8M-$12.5M-$13.7M-$13.3M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$27.3M$21.2M
FY-3$48.5M$28.7M
FY-2$63.8M$28.3M
FY-1$23.5M$6.5M
FY0$123.8M$90.1M
PeriodOCFCapExFCFSBC
FY-4$2.9M-$1.4M$2.5M
FY-3-$180.8k-$5.5M-$9.8M
FY-2$202.7k-$937.6k-$11.4M
FY-1-$101.4k-$932.6k-$22.5M
FY0-$8.4M-$387.8k-$13.3M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$5.2M-$5.0M-$4.1M-$2.0M
FQ-6-$33.6M-$14.2M-$15.7M-$17.0M
FQ-5$4.4M-$1.3M-$1.6M-$1.5M
FQ-4$4.0M-$1.1M-$1.3M-$1.1M
FQ-3$3.2M-$3.6M-$3.8M-$3.6M
FQ-2$4.3M-$6.5M-$6.9M-$7.1M
FQ-1$9.2M$69.2M$66.7M$66.9M
FQ0$8.1M-$175.4M-$178.9M-$215.8M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$56.5M$22.1M
FQ-6$23.5M$6.5M
FQ-5$18.6M$5.0M
FQ-4$17.5M$3.8M
FQ-3$15.1M$1.9M
FQ-2$123.8M$90.1M
FQ-1$419.7M$210.8M
FQ0$271.1M$48.7M
PeriodOCFCapExFCFSBC
FQ-7-$2.8M-$663.1k-$2.0M
FQ-6-$101.4k-$932.6k-$17.0M
FQ-5-$2.0M-$167.4k-$1.5M
FQ-4-$3.4M-$167.4k-$1.1M
FQ-3-$4.1M-$198.0k-$3.6M
FQ-2-$8.4M-$387.8k-$7.1M
FQ-1-$9.8M-$14.8k$66.9M
FQ0-$12.5M-$37.0M-$215.8M
Valuation
Market price$1.52
Market cap$106.0M
Enterprise value$132.7M
P/E
Reported non-GAAP P/E
EV/Revenue25.4
EV/Op income
EV/OCF
P/B4.8
P/Tangible book4.8
Tangible book$22.1M
Net cash-$26.7M
Current ratio0.7
Debt/Equity1.2
ROA-7.3%
ROE-18.7%
Cash conversion68.0%
CapEx/Revenue-12.7%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Personal Products · cohort 185 companies
MetricUPXIActivity
Op margin-96.5%6.0% medp25 0.5% · p75 12.6%bottom quartile
Net margin-78.9%5.2% medp25 0.5% · p75 10.9%bottom quartile
Gross margin24.3%43.2% medp25 26.0% · p75 61.0%bottom quartile
R&D / revenue1.8% medp25 1.8% · p75 1.8%
CapEx / revenue-12.7%-3.0% medp25 -5.5% · p75 -1.3%bottom quartile
Debt / equity121.0%13.3% medp25 2.5% · p75 55.2%top quartile
Observations
IR observations
Mean price target5.00 USD
Median price target5.00 USD
High price target8.00 USD
Low price target2.00 USD
Mean recommendation2.00 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count2.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate-1.94 USD
Last actual EPS-1.73 USD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-16 14:52 UTC#a1c08788
Market quoteclose USD 1.34 · shares 0.07B diluted
no public URL
2026-05-16 14:52 UTC#c9811e6f
Source: analysis-pipeline (hybrid)Generated: 2026-05-29 21:12 UTCJob: 8ee5f449